- Home
- PRLD vs SWVL Comparison
PRLD vs SWVL Comparison
Compare PRLD & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SWVL
- Stock Information
- Founded
- PRLD 2016
- SWVL 2017
- Country
- PRLD United States
- SWVL United Arab Emirates
- Employees
- PRLD N/A
- SWVL N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SWVL Business Services
- Sector
- PRLD Health Care
- SWVL Consumer Discretionary
- Exchange
- PRLD Nasdaq
- SWVL Nasdaq
- Market Cap
- PRLD 50.1M
- SWVL 50.6M
- IPO Year
- PRLD 2020
- SWVL N/A
- Fundamental
- Price
- PRLD $0.78
- SWVL $3.06
- Analyst Decision
- PRLD Strong Buy
- SWVL
- Analyst Count
- PRLD 2
- SWVL 0
- Target Price
- PRLD $4.50
- SWVL N/A
- AVG Volume (30 Days)
- PRLD 110.2K
- SWVL 9.9K
- Earning Date
- PRLD 05-06-2025
- SWVL 05-20-2025
- Dividend Yield
- PRLD N/A
- SWVL N/A
- EPS Growth
- PRLD N/A
- SWVL N/A
- EPS
- PRLD N/A
- SWVL N/A
- Revenue
- PRLD $7,000,000.00
- SWVL $17,207,362.00
- Revenue This Year
- PRLD N/A
- SWVL N/A
- Revenue Next Year
- PRLD N/A
- SWVL N/A
- P/E Ratio
- PRLD N/A
- SWVL N/A
- Revenue Growth
- PRLD N/A
- SWVL N/A
- 52 Week Low
- PRLD $0.61
- SWVL $2.40
- 52 Week High
- PRLD $6.80
- SWVL $11.98
- Technical
- Relative Strength Index (RSI)
- PRLD 46.96
- SWVL 43.96
- Support Level
- PRLD $0.73
- SWVL $2.92
- Resistance Level
- PRLD $1.00
- SWVL $3.15
- Average True Range (ATR)
- PRLD 0.09
- SWVL 0.26
- MACD
- PRLD -0.01
- SWVL 0.05
- Stochastic Oscillator
- PRLD 18.96
- SWVL 28.48
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.